Acute kidney injury is common in critically ill children admitted to the intensive care unit. The etiology of acute kidney injury is multifactorial and the incidence varies between 1 and 41% (Krishnamurthy, 2013) probably due to the different definitions used in clinical studies. Unfortunately, Serum Creatinine (the main acute kidney injury biomarker used in the clinical setting) is a late marker of reduced glomerular filtration rate, which limits the ability to detect acute kidney injury early and to initiate clinical therapeutic studies. Therefore, Diagnostic specificity and sensitivity of new biomarkers are currently weighed against creatinine-based criteria (Waikar et al., 2009). Several proteins and biochemical markers emerged as sensitive and specific biomarkers capable of the early detection of acute tubular injury (Devarajan, 2011). The most famous of these biomarkers is neutrophil gelatinase-associated lipocalin (NGAL).
INTRODUCTION
Pediatric AKI is largely asymptomatic and often occurs in the wake of other underlying conditions such as cardiac surgical procedures, critical illness, and nephrotoxin use. Making the diagnosis in the estimated 5% of all hospitalized children and ~30% of critically ill neonates and children who suffer from AKI and its consequences currently depends on serial measurements of functional biomarkers such as serum creatinine. This approach is flawed due to several reasons. [Devarajan, 2010] [ Devarajan, 2013] First, non-renal factors such as age, gender, diet, muscle mass, and medications can influence serum creatinine concentration independent of changes in kidney structure or function. Serum creatinine in a neonate is merely reflective of maternal creatinine for approximately the first 10 days of life. GFR is normally low in infants, and physiological maturation of renal function occurs until 2 years of age. Children with chronic conditions such as congenital heart disease display low muscle mass, resulting in falsely lowered serum creatinine. Second, a previously healthy kidney displays a significant functional reserve, such that >50% of kidney function can be lost due to an acute damaging insult without any change in serum creatinine. This is especially true in the pediatric population, where the lack of chronic comorbid conditions generally results in pristine kidneys with maximal functional reserve. Third, a rise in serum creatinine concentration accompanies any condition that leads to transient renal hypoperfusion. These episodes of "pre-renal azotemia" are common in children with gastrointestinal illness and must be differentiated from the more ominous forms of "intrinsic AKI" with accompanying structural damage. Fourth, there is typically a lag period of hours to days after an acute injurious event before serum creatinine rises. During this time, structural damage is known to occur to the kidney tubules. Accumulated
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experimental data have identified several interventions that can prevent and/or treat AKI during this "subclinical" phase before the serum creatinine rises. The paucity of an early biomarker of structural AKI has hampered our ability to translate these promising interventions to human AKI in a timely manner. The search for biomarkers for the early diagnosis of AKI and its outcomes is an area of intense contemporary research that has yielded several promising candidates. A select few that are especially pertinent to pediatric AKI are summarized in the following.
NGAL [Neutrophil gelatinaseassociated lipocalin]
The most extensively studied and promising biomarker in pediatric AKI is NGAL. [Ciccia & Devarajan 2017] Preclinical gene expression analyses reported in >150 distinct studies performed in AKI models from several species ranging from rodents to humans have consistently revealed the NGAL gene to be one of the most dramatically upregulated genes in the kidney soon after an ischemic or a nephrotoxic insult.
[Supavekin et al2003] [ Devarajan, 2015] The NGAL protein is also highly induced in regenerating and recovering kidney tubule cells. [Mishra et al., 2003 ] NGAL binds to iron; chelation of toxic iron is an important mechanism that protects the kidney tubules from worsening injury. Thus, the biologic role of NGAL in AKI is one of enhanced tubule cell proliferation and recovery [Mishra et al., 2004] . The induced NGAL protein is rapidly secreted into both the urine and the plasma in animal models of AKI, and a decade of translational studies in human beings have now established NGAL as a biomarker to predict AKI and its adverse outcomes independent of serum creatinine.
Cardiac
surgery-associated acute kidney injury (CS-AKI) is a common cause of AKI in children, with a reported incidence of 20-60%. [Jefferies & Devarajan 2016 ] However, the increase in serum creatinine typically occurs only 1 -3 days after a cardiopulmonary bypass (CPB). As first highlighted by Mishra et al,[Mishra et al2005] a dramatic increase in both urine and plasma NGAL is detected within 2-6 hours of CPB in children destined for AKI, with a predictive area under the receiver operating characteristic curve (AUC) of >0.9. These findings have now been confirmed in >7500 patients, [HaaseFielitz et al2014] [Zhou et al2016] with measurements obtained within 4 -6 hours after initiation of CPB, yielding an overall predictive pooled AUC of 0.86. The predictive performance for CSAKI was similar for both urine and plasma NGAL. Subgroup analyses revealed that NGAL displays the highest predictive accuracy for CS-AKI in children (AUC 0.89 versus 0.83 in adults) and in subjects without preexisting renal insufficiency (AUC 0.87 versus 0.81 with pre-existing renal insufficiency). Critical illness, including sepsis, is the most common cause of AKI worldwide, with a reported incidence of 30-50%. The ability of NGAL to predict AKI in this heterogeneous population has been confirmed in >8500 critically ill patients,[HaaseFielitz et al2014] with measurements obtained within 6 hours of clinical presentation yielding an overall predictive AUC of 0.8.11 [Basu et al2014] In a recent metaanalysis28 [Zhou et al2016] specifically examining the value of NGAL for the prediction of AKI in patients with sepsis, the specificity of plasma NGAL for predicting AKI was inferior to that of urine NGAL in sepsis, although the sensitivities and pooled AUCs were 
Interleukin-18
Animal studies have shown that IL-18 is induced in the proximal tubule and detectable in the urine following ischemic AKI. [Ciccia & Devarajan 2017] IL-18 represents a proinflammatory cytokine that might worsen the degree of AKI. In children undergoing CPB, urinary IL-18 is an early, predictive biomarker, with levels increased at 6-hour post-CPB and an AUC of 0.75 for predicting AKI. 
